Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,otherLiab,otherAssets,totalCurrentLiabilities,totalCurrentAssets,netReceivables,longTermDebt,accountsPayable,changeToNetincome,changeToLiabilities,WC,language,region,quoteType,triggerable,quoteSourceName,currency,market,shortName,esgPopulated,tradeable,exchange,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchangeDataDelayedBy,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,longName,fullExchangeName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,country,website,maxAge,address1,industry,address2
t0,GNCP,-19124403.0,203132992,,,-286405,,-286405,67320,0,-67320,-67320,,-219085,,,,0,0,67320,0,-219085,,-286405,-286405,3893606.0,19547130.0,-19124403.0,422727.0,2658.0,-23020667.0,1918760.0,54027.0,68976.0,368700.0,368700.0,17559394.0,9425.0,286405,0,299724.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,GNCC CAPITAL INC,False,False,PNK,0.0003,1630526393,0.0,0.0003,0.0003,0.0001,115427003,PREPRE,0,4,0.0,1.0E-4 - 3.0E-4,0.0003,0.0,0.0,0,0,finmb_1038310,"GNCC Capital, Inc.",Other OTC,USD,336690326,283335803,0.00025,5.0000005,5.0E-5 - 0.0037,-0.0034,-0.9189189,5e-05,0.0037,-0.006,-0.094,0.0004222222,-0.00012222218,-0.2894736,0.0010815385,-0.0007815385,-0.7226173,60939,-0.0031914897,15,America/New_York,EDT,-14400000,0.5,,,0.0037,0.0,0.0004,0.0011,336.69M,283.34M,203.13M,,,0.00%,0.00%,,,,,,,,,,,,,,,,"Sep 29, 2012","Sep 29, 2012",0.00%,0.00%,-98.08%,,,,,,,-1.32M,-0.0060,,,,17.61M,,5.34,-0.09,,,Value,89107,Basic Materials,"GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.",Las Vegas,702 990 0156,NV,United States,http://www.gncc-capital.com,86400,848 North Rainbow Boulevard,Gold,Suite No. 4870
t-1,GNCP,-18837998.0,203132992,,,-464935,,-464935,157874,0,-161674,-161674,,-257542,,,,0,0,161674,0,-303261,,-464935,-464935,3893606.0,19281675.0,-18837998.0,443677.0,2658.0,-22734262.0,1700871.0,74977.0,77795.0,368700.0,368700.0,17503009.0,19440.0,464935,0,290905.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,GNCC CAPITAL INC,False,False,PNK,0.0003,1630526393,0.0,0.0003,0.0003,0.0001,115427003,PREPRE,0,4,0.0,1.0E-4 - 3.0E-4,0.0003,0.0,0.0,0,0,finmb_1038310,"GNCC Capital, Inc.",Other OTC,USD,336690326,283335803,0.00025,5.0000005,5.0E-5 - 0.0037,-0.0034,-0.9189189,5e-05,0.0037,-0.006,-0.094,0.0004222222,-0.00012222218,-0.2894736,0.0010815385,-0.0007815385,-0.7226173,60939,-0.0031914897,15,America/New_York,EDT,-14400000,0.5,,,0.0037,0.0,0.0004,0.0011,336.69M,283.34M,203.13M,,,0.00%,0.00%,,,,,,,,,,,,,,,,"Sep 29, 2012","Sep 29, 2012",0.00%,0.00%,-98.08%,,,,,,,-1.32M,-0.0060,,,,17.61M,,5.34,-0.09,,,Value,89107,Basic Materials,"GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.",Las Vegas,702 990 0156,NV,United States,http://www.gncc-capital.com,86400,848 North Rainbow Boulevard,Gold,Suite No. 4870
t-2,GNCP,-18373063.0,203132992,,,-305615,,-305615,84828,0,-94628,-94628,,-210987,,,,0,0,94628,0,-210987,,-305615,-305615,3893606.0,18451303.0,-18373063.0,78240.0,2658.0,-22269327.0,1450663.0,78240.0,216640.0,,,16784000.0,6410.0,294715,0,,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,GNCC CAPITAL INC,False,False,PNK,0.0003,1630526393,0.0,0.0003,0.0003,0.0001,115427003,PREPRE,0,4,0.0,1.0E-4 - 3.0E-4,0.0003,0.0,0.0,0,0,finmb_1038310,"GNCC Capital, Inc.",Other OTC,USD,336690326,283335803,0.00025,5.0000005,5.0E-5 - 0.0037,-0.0034,-0.9189189,5e-05,0.0037,-0.006,-0.094,0.0004222222,-0.00012222218,-0.2894736,0.0010815385,-0.0007815385,-0.7226173,60939,-0.0031914897,15,America/New_York,EDT,-14400000,0.5,,,0.0037,0.0,0.0004,0.0011,336.69M,283.34M,203.13M,,,0.00%,0.00%,,,,,,,,,,,,,,,,"Sep 29, 2012","Sep 29, 2012",0.00%,0.00%,-98.08%,,,,,,,-1.32M,-0.0060,,,,17.61M,,5.34,-0.09,,,Value,89107,Basic Materials,"GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.",Las Vegas,702 990 0156,NV,United States,http://www.gncc-capital.com,86400,848 North Rainbow Boulevard,Gold,Suite No. 4870
t-3,GNCP,-18067448.0,203132992,,,-260115,,-260115,36928,0,-49128,-49128,,-210987,,,,0,0,49128,0,-210987,,-260115,-260115,3893606.0,18172888.0,-18067448.0,105440.0,2658.0,-21963712.0,1239676.0,105440.0,149212.0,,,16784000.0,7912.0,260115,0,,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,GNCC CAPITAL INC,False,False,PNK,0.0003,1630526393,0.0,0.0003,0.0003,0.0001,115427003,PREPRE,0,4,0.0,1.0E-4 - 3.0E-4,0.0003,0.0,0.0,0,0,finmb_1038310,"GNCC Capital, Inc.",Other OTC,USD,336690326,283335803,0.00025,5.0000005,5.0E-5 - 0.0037,-0.0034,-0.9189189,5e-05,0.0037,-0.006,-0.094,0.0004222222,-0.00012222218,-0.2894736,0.0010815385,-0.0007815385,-0.7226173,60939,-0.0031914897,15,America/New_York,EDT,-14400000,0.5,,,0.0037,0.0,0.0004,0.0011,336.69M,283.34M,203.13M,,,0.00%,0.00%,,,,,,,,,,,,,,,,"Sep 29, 2012","Sep 29, 2012",0.00%,0.00%,-98.08%,,,,,,,-1.32M,-0.0060,,,,17.61M,,5.34,-0.09,,,Value,89107,Basic Materials,"GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.",Las Vegas,702 990 0156,NV,United States,http://www.gncc-capital.com,86400,848 North Rainbow Boulevard,Gold,Suite No. 4870
